3 stocks Neil Woodford should buy more of

I believe that these three Neil Woodford stocks look undervalued.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Here are three under-the-radar Neil Woodford holdings that I believe are worth buying today. 

Used cars 

BCA Marketplace (LSE: BCA) owns and operates vehicle buying services across Europe, such as the well-known UK brand, We Buy Any Car.

Over the past five years, this company has grown from an upstart, into a multi-billion pound business. For the fiscal year ending 31 March 2018, City analysts have pencilled in a pre-tax profit of £108m, up from a loss of £0.3m for 2014. As profits have flowed, BCA’s shares have doubled in value since 2014. 

And even though some analysts are becoming concerned about the current state of the UK car market, I believe BCA’s growth will continue.

As new car sales are falling, used car transactions are holding up well. For example, 1.6m new cars joined British roads during the first eight months of the year, down 2.4% year-on-year. However, during the first half of 2017, used car sales grew 1.3% year-on-year to 4.2m. 

As the volume of used car transactions continues to grow, and BCA bolts-on more growth, City analysts expect the company’s earnings per share to expand by 15% this fiscal year, and 12% for 2019. The shares currently trade at a forward P/E of 19.8 and support a dividend yield of 3.6%. 

Growth champion 

Speciality pharmaceutical company BTG (LSE: BTG) is projected to grow earnings per share by 29% for the fiscal year ending 31 March 2018 as pre-tax profit surges 370%. 

At the beginning of July, management confirmed that the company is on track to hit this target as it is set to achieve “double-digit product sales growth” for the year ending March 31 2018, driven by growth in its interventional medicines business. As well as growth in the established business, BTG is progressing well with the development of new products, receiving positive outcomes from two clinical trials for its blood clot treatment Ekos, varicose vein treatment Varithena and PneumRx coils products.

Shares in BTG are not cheap, trading at a forward P/E of 22.2 but considering the company’s growth rate, and treatment pipeline, I believe this is a premium worth paying. Indeed, at the time of writing, the shares are trading at a PEG ratio of 0.8, implying that they offer growth at a reasonable price. 

Property income 

New River REIT (LSE: NRR) owns and operates a portfolio of shopping centres, retail warehouses, public houses and mixed-use development opportunities.  

Neil Woodford clearly likes New River because of the company’s dividend potential. As a REIT, the company has to pay 90% of its rental income out to investors. This year the firm is projected to earn 21.5p and pay 20.7p to investors for a dividend yield of 6%. I believe investors could be in line for a higher distribution however as last year the company issued a 3p per share special dividend at the end of the year, increasing the full-year payout by 24%. 

Over the past five years, shares in New River have produced a return for investors of 87% excluding dividends. Including dividends, the shares have delivered a total return of 111%.

The one downside is that due to New River’s generous dividend policy, the shares trade at a 17% premium to the net asset value of 292p as reported at the end of 2016. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended BTG. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »